The complexation efficiency

Studies have shown that cyclodextrins form both inclusion and non-inclusion complexes and that several different types of complexes can coexist in aqueous solutions. In addition, both cyclodextrins and cyclodextrin complexes are known to form aggregates and it is thought that these aggregates are able to solubilize drugs through micellar-type mechanism. Thus, stability constants determined from phase-solubility profiles are rarely true stability constants for of some specific drug/cyclodextrin complexes. A more precise method for evaluation of the solubilizing effects of cyclodextrins is to determine their complexation efficiency (CE). CE can be determined by measuring the solubility of a given drug at 2–3 cyclodextrin concentrations in pure water or a medium constituting the pharmaceutical formulation such as parenteral solution or aqueous eye drop formulation. Based on the CE value the drug:cyclodextrin ratio in the complexation medium can be determined as well as the increase in the formulation bulk in a solid dosage form. Determination of CE is a simple method for quick evaluating the solubilizing effects of different cyclodextrins and/or the effects of excipients on the solubilization. Here we report the CE of 43 different drugs with mainly 2-hydroxypropyl-β-cyclodextrin but also with randomly methylated β-cyclodextrin as well as few other cyclodextrins. Calculation of CE, drug:cyclodextrin molar ratio and the increase in the formulation bulk is discussed, as well as the influence of the intrinsic solubility and drug lipophilicity on the CE.

[1]  I. Warner,et al.  Phase transition pattern of 2,5-diphenyloxazole/γ-cyclodextrin (PPO/γ-CD) self-assembly aggregates , 1995 .

[2]  M. Brewster,et al.  Alfaxalone: Effect of Temperature on Complexation with 2-Hydroxypropyl-β-cyclodextrin , 2002 .

[3]  Piero Baglioni,et al.  Self-assembly of beta-cyclodextrin in water. Part 1: Cryo-TEM and dynamic and static light scattering. , 2006, Langmuir : the ACS journal of surfaces and colloids.

[4]  Andrea Mele,et al.  Non-covalent associations of cyclomaltooligosaccharides (cyclodextrins) with trans-β-carotene in water: evidence for the formation of large aggregates by light scattering and NMR spectroscopy , 1998 .

[5]  M. Másson,et al.  The effects of water-soluble polymers on cyclodextrins and cyclodextrin solubilization of drugs , 2004 .

[6]  T. Loftsson,et al.  Determination of aqueous solubility by heating and equilibration: A technical note , 2006, AAPS PharmSciTech.

[7]  Thorsteinn Loftsson,et al.  Self Association and Cyclodextrin Solubilization of NSAIDs , 2002 .

[8]  T. Higuchi,et al.  Phase solubility techniques , 1965 .

[9]  M. Brewster,et al.  Self-association of cyclodextrins and cyclodextrin complexes. , 2004, Journal of pharmaceutical sciences.

[10]  J. van Stam,et al.  Higher-Order Cyclodextrin Complexes: The Naphthalene System , 2004 .

[11]  J. Beloeil,et al.  Study of inclusion complexes of acridine with β‐ and (2,6‐di‐O‐methyl)‐β‐cyclodextrin by use of solubility diagrams and NMR spectroscopy , 2002 .

[12]  G. González‐Gaitano,et al.  The Aggregation of Cyclodextrins as Studied by Photon Correlation Spectroscopy , 2002 .

[13]  E. De Pauw,et al.  Influence of response factors on determining equilibrium association constants of non-covalent complexes by electrospray ionization mass spectrometry. , 2003, Journal of mass spectrometry : JMS.

[14]  A. Coleman,et al.  Aggregation of cyclodextrins: An explanation of the abnormal solubility ofβ-cyclodextrin , 1992 .

[15]  M. Másson,et al.  Cyclodextrins in drug delivery , 2005, Expert opinion on drug delivery.

[16]  AC Moffat,et al.  Clarke's analysis of drugs and poisons , 2003 .

[17]  Tetsumi Yamakawa,et al.  Liquid formulation of a novel non-fluorinated topical quinolone, T-3912, utilizing the synergic solubilizing effect of the combined use of magnesium ions and hydroxypropyl-beta-cyclodextrin. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[18]  E. Pauw,et al.  On the specificity of cyclodextrin complexes detected by electrospray mass spectrometry , 2002, Journal of the American Society for Mass Spectrometry.

[19]  M. Másson,et al.  Methods to enhance the complexation efficiency of cyclodextrins , 1999 .

[20]  D. Gill,et al.  Extended 2,5-diphenyloxazole-.gamma.-cyclodextrin aggregates emitting 2,5-diphenyloxazole excimer fluorescence , 1988 .

[21]  Y. E. Shapiro,et al.  Inclusion compounds of psychotropic agents and cyclodextrins , 1996 .

[22]  Thorsteinn Loftsson,et al.  Self-association and cyclodextrin solubilization of drugs. , 2002, Journal of pharmaceutical sciences.

[23]  D. Paolino,et al.  Preparation of celecoxib-dimethyl-beta-cyclodextrin inclusion complex: characterization and in vitro permeation study. , 2005, European journal of medicinal chemistry.

[24]  H. Ohmori,et al.  2H NMR study of the self-assembly of an azo dye-cyclomaltooctaose (γ-cyclodextrin) complex , 1994 .

[25]  Thorsteinn Loftsson,et al.  Evaluation of cyclodextrin solubilization of drugs. , 2005, International journal of pharmaceutics.

[26]  T. Loftsson,et al.  Cyclodextrin solubilization of the antibacterial agents triclosan and triclocarban: formation of aggregates and higher-order complexes. , 2005, International journal of pharmaceutics.

[27]  M. Brewster,et al.  Role of cyclodextrins in improving oral drug delivery , 2004 .

[28]  M. Másson,et al.  Cyclodextrins and drug permeability through semi-permeable cellophane membranes. , 2002, International journal of pharmaceutics.